Redefining Psoriasis Care: A Collaborative Journey for Better Patient Outcomes hsj.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hsj.co.uk Daily Mail and Mail on Sunday newspapers.
Bristol Myers Squibb UK and Ireland has been announced as the first biopharmaceutical company in the UK to be accredited as a Menopause Friendly Workplace. Menopause Friendly accreditation is a recognised standard of achievement awarded by an independent panel of judges, recognising employers who put diversity .
Skin cancer survival rates were significantly improved in patients who took a combination of immunotherapy drugs but serious side effects were reported in 59% of patients Almost half of the patients with advanced skin cancer who were treated with two immunotherapy drug were still alive six and a half years later. Of the 49% who survived, 77% required no further treatment after receiving nivolumab plus ipilimumab, compared to 69% and 43% who received the drugs separately. Experts say the results signify an important landmark, representing the longest median overall survival rate reported in a randomised controlled trial for advanced melanoma. The combination of nivolumab and ipilimumab has been available through the NHS as a first-line option for these patients since 2016.